文章预览
The article discusses China’s new healthcare policies, analyzing their potential trends. By丨 Feng Wang,Anyi Wang, Fengyi Liu, Anqi Fan The article outlines the background of the introduction of China’s new healthcare policies, highlighting the risks for foreign enterprises’ investment under these regulations and the impact of US legislation on biotechnology and data security. By strategically planning and allocating resources from the outset, foreign enterprises can expect significant returns in the medium to long term, thanks to progressive implementation of policies and sustained growth of market demands. On September 7, 2024, the Ministry of Commerce, the National Health Commission, and the National Medical Products Administration jointly issued the “ Notice on Carrying out Pilot Program to Expand Opening up in the Healthcare Field ” (the “Notice” [1] ) (see the attachments of this article for the complete bilingual versions of the Notice in Chinese and English), pro
………………………………
